Watch videos from the CLL Conference in Toronto on November 16, 2019:
Dr. David Andrews - CLL Research Highlights and Research Advances
Dr. David Spaner - CLL Diagnosis and Managing Symptoms
Dr Vighnesh Bharath - CLL – Treatment Options; New drugs; Coverage
Mark Silverstein - CLL Survivor and Patient Forum
Sarah Khan - LLSC Programs and Services
David W. Andrews, Ph.D.
Director and Senior Scientist, Biological Sciences, Sunnybrook Research Institute
Canada Research Chair in Membrane Biogenesis
Professor, Departments of Biochemistry and Medical Biophysics, University of Toronto
Dr. David Andrews is Director of and Senior Scientist in Biological Sciences at Sunnybrook Research Institute (SRI), Professor of Biochemistry and Medical Biophysics at University of Toronto and a Tier 1 Canada Research Chair in membrane biogenesis. He has published over 150 research articles with an h-index factor of ~60 and over 15,000 citations. His research includes, the molecular mechanisms by which Bcl-2 family proteins regulate apoptosis at mitochondria, the assembly of proteins into membranes, high-content screening and development of new microscopes for fluorescence lifetime imaging microscopy (FLIM) and hyperspectral imaging. His discovery research is funded by a Foundation grant from the Canadian Institutes of Health Research (CIHR) and equipment funding from the Canada Foundation for Innovation and the Ontario Ministry of Research and Innovation.
Dr. Andrews is active in the public and private sector. In recent years he was president of the Society for Biomolecular Imaging and Informatics. He participated in the start-up of two companies, MBI Fermentas and Isogenica. He consults for several other companies and academic centers. His group performs contract research for a variety of biotech companies. He holds licensed patents in areas such as translational regulation, in vitro evolution and peptide display technologies.
Dr. David Spaner, MD, PhD, FRCP
Senior Scientist at Sunnybrook Research Institute
Hematologist/Oncologist at Sunnybrook Hospital
2017 recipient of the UFCW Canada Award for Leukemia Research.
Dr. David Spaner is a Senior Scientist, Biological Sciences, Odette Cancer Research Program, Sunnybrook Research Institute and an Associate professor, department of medical biophysics, University of Toronto
He is renowned for his work in Chronic Lymphocytic Leukemia (CLL) and the goal of his research laboratory is to understand the biology of this cancer and develop better treatments for it.
Chronic lymphocytic leukemia (CLL) is the most common leukemia in Canada and is often fatal. A new drug called Ibrutinib has been of great help to CLL patients but does not cure them. Dr. Spaner's group has found that CLL cells are kept alive in the presence of Ibrutinib by proteins called cytokines. Learning the best way to block the effects of cytokines should improve the lives of patients on Ibrutinib.
Vighnesh Bharath, M.D.
Hematologist/ Oncologist at Humber River Hospital
Adjunct Professor Queen’s University
Dr. Vighnesh Bharath is currently a hematologist/oncologist at Humber River Hospital, specializing in both benign and malignant hematology. Within the malignant realm, he treats patients with leukemia, lymphoma, and multiple myeloma. He is also an active member of various hospital committees including the Transfusion Medicine Committee and Anticoagulation Committee. He enjoys teaching and is currently Adjunct Professor at Queen’s University. He conducts regular teaching sessions for rotating students at the hospital. Outside of work, you might find Vighnesh reading historical fiction, traveling, or dabbling in photography.
To learn more, contact Sarah Khan, Community Engagement Manager, Ontario
This event was made possible thanks to the support of: